# Diane Brouilliard

> Diane Brouilliard is a Series B investor at Sante Ventures backing Health Care and Biotechnology. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Sante Ventures](https://shizune.co/investors/profile/sante-ventures)
- Location: Austin, United States
- Total investments: 2
- Last investment: Feb 2020
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/dianebrouillard/

Diane Brouilliard is a Series B investor at Sante Ventures in Austin focused on Health Care and Biotechnology. Diane Brouilliard Head of Talent and Networks at Sante Ventures. Diane holds a bachelor of science degree in human organizational development at Vanderbilt University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 50% |
| Biotechnology | 1 | 50% |
| Medical Device | 1 | 50% |
| Health Diagnostics | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 50% |
| Series C | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| BioStable | BioStable is a cardiovascular device company that develops innovative new products for the treatment of cardiovascular diseases. The company is led by an experienced group of industry executives with expertise in rapid and effective medical device development. The organization incorporates core strengths in all areas of product developmentincluding quality systems, design, engineering, prototyping and pilot production, in-vitro and in-vivo testing, manufacturing, global regulatory relationships, clinical product validation, market launch, and distribution. BioStable provides a competitive edge by minimizing time to market for cost-effective medical devices that deliver improved clinical outcomes. The company focused on developing and commercializing proprietary valve repair technologies that provide an alternative to valve replacement for patients with aortic valve disease.BioStable was founded in |  | Series C | Feb 25, 2020 |  |
| BioStable | BioStable is a cardiovascular device company that develops innovative new products for the treatment of cardiovascular diseases. The company is led by an experienced group of industry executives with expertise in rapid and effective medical device development. The organization incorporates core strengths in all areas of product developmentincluding quality systems, design, engineering, prototyping and pilot production, in-vitro and in-vivo testing, manufacturing, global regulatory relationships, clinical product validation, market launch, and distribution. BioStable provides a competitive edge by minimizing time to market for cost-effective medical devices that deliver improved clinical outcomes. The company focused on developing and commercializing proprietary valve repair technologies that provide an alternative to valve replacement for patients with aortic valve disease.BioStable was founded in | $4.3M | Series B | Apr 29, 2015 |  |

2 of 2 investments shown.

## Co-investors
- [Longmeadow Capital Partners](https://shizune.co/investors/profile/longmeadow-capital-partners) — VC Fund, 1 deal together
- [Orlando Health Ventures](https://shizune.co/investors/profile/orlando-health-ventures) — VC Fund, 1 deal together
- [Rex Health Ventures](https://shizune.co/investors/profile/rex-health-ventures) — VC Fund, 1 deal together
- [Solas BioVentures](https://shizune.co/investors/profile/solas-bioventures) — VC Fund, 1 deal together

## About Sante Ventures

VC Fund · Austin, United States

Santé Ventures is a life sciences venture capital firm that invests exclusively in early-stage companies developing innovative new medical technologies or healthcare delivery models. The firm was founded in 2006 and has nearly $1 billion in capital under management.

5 contacts available at Sante Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Casey Cunningham | Partner & Chief Scientific Officer | https://shizune.co/investors/profile/casey-cunningham |
| David Kaufman | Chief Operating Officer | https://shizune.co/investors/profile/david-kaufman-ac63 |
| Dennis McWilliams | Managing Director | https://shizune.co/investors/profile/dennis-mcwilliams |
| Diane Brouilliard | Head of Talent & Networks | https://shizune.co/investors/profile/diane-brouilliard |
| Douglas French | Co-Founder and Managing Director | https://shizune.co/investors/profile/douglas-d-french |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Diane Brouilliard invest in?

Diane Brouilliard invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Series B and Series C stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Diane Brouilliard last invest?

The most recent investment recorded for Diane Brouilliard closed in Feb 2020. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co